Ro Khanna U.S. House of Representatives from California's 17th district | Official U.S. House Headshot
Ro Khanna U.S. House of Representatives from California's 17th district | Official U.S. House Headshot
Rep. Ro Khanna, currently serving in the U.S. Congress representing California's 17th district, has recently shared his views on several key issues through a series of tweets. Known for his advocacy in education and healthcare reform, Khanna addressed concerns about potential impacts on families if the Department of Education were to be eliminated, the affordability of prescription drugs, and the financial implications of the election season.
On November 18, 2024, Rep. Khanna expressed concerns about proposals to dismantle the Department of Education. He stated that such actions "will impact families" by negatively affecting children with dyslexia and autism, students relying on Pell Grants, those who receive school lunches, and individuals attending low-income schools. Reflecting on his own experiences as a former public school student who utilized loans for college, he emphasized the potential adverse effects here.
The following day, November 19, 2024, Khanna addressed healthcare affordability issues by noting that "60% of adults taking prescription drugs" are worried about affording their medication. While acknowledging that a "$35 insulin cap is a start," he insisted it is insufficient. He advocated for passing his Prescription Drug Price Relief Act in collaboration with Senator Bernie Sanders to reduce overall drug costs here.
Later on November 19th, Khanna commented on campaign finance reform amidst reports that spending for the 2024 election season exceeded $20 billion. He declared that "our political system isn't for sale" and called for measures to overturn Citizens United and ban PAC spending to restore democratic processes to American citizens here.